Aterian Investment Partners Acquires Contract Pharmaceuticals Limited
FDA slams Jubilant Generics, Canada`s Contract Pharmaceuticals with Form 483s
Aterian Investment Partners to Recapitalize CPL, a Leading Pharmaceutical Contract Development and Manufacturing Organization
The Board of Directors of Contract Pharmaceuticals Limited (CPL) has appointed Jan Sahai, MBA, PharmD as Chief Executive Officer, effective immediately, reporting to Caitlin Wege, Executive Chair, Board of Directors.
New Aseptic Fill/Finish CMO Launches Operations